Filing Details
- Accession Number:
- 0001415889-23-012360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-17 17:00:19
- Reporting Period:
- 2023-08-16
- Accepted Time:
- 2023-08-17 17:00:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750284 | Olema Pharmaceuticals Inc. | OLMA | Pharmaceutical Preparations (2834) | 300409740 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831410 | Cyrus Harmon | C/O Olema Pharmaceuticals, Inc. 780 Brannan St San Francisco CA 94103 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-16 | 15,000 | $10.14 | 1,023,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 122,028 | Indirect | See Footnote |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated May 16, 2023.
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated May 16, 2023.
- The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.
Billionaire Hedge Funds
